Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001054414 | SCV001218727 | uncertain significance | Congenital myasthenic syndrome 8 | 2023-07-07 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1221 of the AGRN protein (p.Arg1221Trp). This variant is present in population databases (rs374345060, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 850280). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002553347 | SCV003695735 | uncertain significance | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.3661C>T (p.R1221W) alteration is located in exon 22 (coding exon 22) of the AGRN gene. This alteration results from a C to T substitution at nucleotide position 3661, causing the arginine (R) at amino acid position 1221 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |